Literature DB >> 24475454

Hepatitis C virus infection in nephrology patients.

Lionel Rostaing1, Jacques Izopet2, Nassim Kamar1.   

Abstract

CONTEXT: Hepatitis C virus (HCV) infection leads to chronic liver disease, but also to extra-hepatic manifestations. EVIDENCE ACQUISITIONS: Directory of Open Access Journals (DOAJ), Google Scholar, Pubmed (NLM), LISTA (EBSCO) and Web of Science have been searched.
RESULTS: Herein, we provide an overview of renal diseases related to HCV and their therapies, as well as the treatment options available for HCV (+)/RNA (+) dialysis patients. We will not mention, however, HCV infection-related complications in the post-kidney transplantation setting.
CONCLUSIONS: Extra-hepatic manifestations of HCV infection include mixed cryoglobulinemia, lymphoproliferative disorders, and renal disease. HCV infection has been reported in association with distinct histological patterns of glomerulonephritis in native kidneys.

Entities:  

Keywords:  Glomerulonephritis; Hepatitis C; Membranoproliferative glomerulonephritis; Renal transplantation

Year:  2013        PMID: 24475454      PMCID: PMC3891131          DOI: 10.12860/JNP.2013.36

Source DB:  PubMed          Journal:  J Nephropathol        ISSN: 2251-8363


  76 in total

1.  Hepatitis C virus infection and membranous glomerulonephritis.

Authors:  C Rollino; D Roccatello; O Giachino; B Basolo; G Piccoli
Journal:  Nephron       Date:  1991       Impact factor: 2.847

Review 2.  Cryoglobulinemia vasculitis.

Authors:  Patrice Cacoub; Nathalie Costedoat-Chalumeau; Olivier Lidove; Laurent Alric
Journal:  Curr Opin Rheumatol       Date:  2002-01       Impact factor: 5.006

Review 3.  Occult hepatitis C virus infection: a new form of hepatitis C.

Authors:  Vicente Carreño
Journal:  World J Gastroenterol       Date:  2006-11-21       Impact factor: 5.742

4.  Glomerulonephritis in autopsy cases with hepatitis C virus infection.

Authors:  Y Arase; K Ikeda; N Murashima; K Chayama; A Tsubota; I Koida; Y Suzuki; S Saitoh; M Kobayashi; M Kobayashi; M Kobayashi; H Kumada
Journal:  Intern Med       Date:  1998-10       Impact factor: 1.271

5.  Results of hepatitis C virus treatment in patients on hemodialysis: data from published meta-analyses in 2008.

Authors:  T Casanovas Taltavull; C Baliellas Comellas; J M Cruzado Garrit
Journal:  Transplant Proc       Date:  2009 Jul-Aug       Impact factor: 1.066

6.  Interferon and ribavirin treatment in patients with hepatitis C-associated renal disease and renal insufficiency.

Authors:  Annette Bruchfeld; Karin Lindahl; Lars Ståhle; Magnus Söderberg; Robert Schvarcz
Journal:  Nephrol Dial Transplant       Date:  2003-08       Impact factor: 5.992

7.  Glomerulonephritis in renal allografts associated with hepatitis C infection: a possible relationship with transplant glomerulopathy in two cases.

Authors:  B J Gallay; C E Alpers; C L Davis; M F Schultz; R J Johnson
Journal:  Am J Kidney Dis       Date:  1995-10       Impact factor: 8.860

8.  Hepatitis C virus-related cryoglobulinemic glomerulonephritis: long-term remission after antiviral therapy.

Authors:  Paolo Rossi; Tullio Bertani; Piero Baio; Roberta Caldara; Patrizia Luliri; Francesca Tengattini; Piermario Bellavita; Gianna Mazzucco; Rocco Misiani
Journal:  Kidney Int       Date:  2003-06       Impact factor: 10.612

Review 9.  Kidney and liver involvement in cryoglobulinemia.

Authors:  Fabrizio Fabrizi; Patrizia Colucci; Claudio Ponticelli; Francesco Locatelli
Journal:  Semin Nephrol       Date:  2002-07       Impact factor: 5.299

10.  Efficacy and safety of rituximab in type II mixed cryoglobulinemia.

Authors:  Francesco Zaja; Salvatore De Vita; Cesare Mazzaro; Stefania Sacco; Daniela Damiani; Ginevra De Marchi; Angela Michelutti; Michele Baccarani; Renato Fanin; Gianfranco Ferraccioli
Journal:  Blood       Date:  2003-01-30       Impact factor: 22.113

View more
  5 in total

1.  Helicobacter pylori and Serum Magnesium Level in Hemodialysis Patients.

Authors:  Hamid Nasri
Journal:  Jundishapur J Microbiol       Date:  2014-02-01       Impact factor: 0.747

2.  Usefulness of combination therapy with Daclatasvir plus Asunaprevir in chronic hepatitis C patients with chronic kidney disease.

Authors:  Norihiko Morisawa; Yohei Koshima; Jun-Ichi Satoh; Yukio Maruyama; Satoru Kuriyama; Takashi Yokoo; Morimasa Amemiya
Journal:  Clin Exp Nephrol       Date:  2016-10-22       Impact factor: 2.801

Review 3.  Opportunities for treatment of the hepatitis C virus-infected patient with chronic kidney disease.

Authors:  Marco Ladino; Fernando Pedraza; David Roth
Journal:  World J Hepatol       Date:  2017-07-08

4.  Epidemiology of chronic kidney diseases in the Republic of Guinea; future dialysis needs.

Authors:  Alpha Oumar Bah; Cisse Lamine; Mamadou Cellou Balde; Mamadou Lamine Yaya Bah; Lionel Rostaing
Journal:  J Nephropathol       Date:  2015-10-01

5.  Evaluation of the Pharmacokinetics and Renal Excretion of Simeprevir in Subjects with Renal Impairment.

Authors:  Sivi Ouwerkerk-Mahadevan; Maria Beumont-Mauviel; Steven Mortier; Monika Peeters; Rene Verloes; Carla Truyers; Geert Mannens; Inneke Wynant; Alexandru Simion
Journal:  Drugs R D       Date:  2015-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.